SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-038049
Filing Date
2024-03-28
Accepted
2024-03-28 16:14:08
Documents
89
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K achv-20231231.htm   iXBRL 10-K 3146781
2 EX-10.10 achv-ex10_10.htm EX-10.10 48690
3 EX-10.21 achv-ex10_21.htm EX-10.21 172990
4 EX-10.32 achv-ex10_32.htm EX-10.32 92852
5 EX-21.1 achv-ex21_1.htm EX-21.1 2963
6 EX-23.1 achv-ex23_1.htm EX-23.1 3337
7 EX-31.1 achv-ex31_1.htm EX-31.1 11203
8 EX-32.1 achv-ex32_1.htm EX-32.1 5204
9 EX-97.0 achv-ex97_0.htm EX-97.0 81305
  Complete submission text file 0000950170-24-038049.txt   12480287

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT achv-20231231.xsd EX-101.SCH 1800117
93 EXTRACTED XBRL INSTANCE DOCUMENT achv-20231231_htm.xml XML 2108794
Mailing Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021
Business Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 033-80623 | Film No.: 24799087
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)